Innovation at Ryniant
Discover the Future
Revolutionizing Therapeutics development with Ominor
Revolutionize healthcare with Ominor Platform. Utilizing AI and real-world data, we accelerate treatments for rare, neglected, and complex diseases. Our innovative approach integrates machine learning and multi-omics analysis to predict, optimize, and validate drug candidates. Join us in democratizing research and making life-saving innovation accessible to all.
We want to use this platform to be the basis of our subsidiaries, meaning that each subsidiary uses their own version of the platform trained specifically on their specific area of endeavor.
Development of the Ominor Platform is not complete and requires additional funding to complete.
Discover the Future
Revolutionizing Public Health with Bluvia
The Bluvia h1 is an app designed to inform the public, policy makers, and companies about health risks heavy metal contamination in sediment and urban waterways. Bluvia's h1 uses Scanning Electron Microscopy EDS data along with a state of the art AI regression model to predict the concentrations of certain heavy metal species in a chosen location's sediment with high accuracy. This allows members of the public, policy makers, and companies to be better informed about the possible public health risks of an area as they are now easily able to quantify the contamination by heavy metals in an area to a high accuracy.
Ryniant Sciences wants to use Bluvia's h1 app to partner with real estate companies to allow home buyers know of the potential heavy metal contamination health risks when considering choices for a home.
Bluvia's h1 has the potential to improve/guide policy, provide health risk transparency, and provide businesses with tools to improve their products. Donate to help improve the quality of Bluvia's h1 app and help make public health risks more visible.
Discover the Future
Revolutionizing Health Informatics with Calrivis Alpha z1
Calrivis, a subsidiary of Ryniant Sciences, is dedicated to revolutionizing medical imaging and diagnostics through AI-powered precision technology. Our flagship innovation, the Calrivis Alpha Z1, is an advanced AI system that detects brain tumors from MRI scans with unparalleled accuracy. By leveraging deep learning and medical imaging analysis, the Alpha Z1 enhances early detection, aiding in faster diagnosis and improved treatment planning. Designed to integrate seamlessly with existing radiology workflows, Calrivis empowers healthcare professionals with cutting-edge AI diagnostics, reducing misdiagnoses and improving patient outcomes. At Calrivis, we are committed to making advanced medical imaging more accurate, efficient, and accessible for global healthcare.
